GM

Geoffrey von Maltzahn

ST Seres Therapeutics: 5 patents #1 of 10Top 10%
AG Ait Austrian Institute Of Technology Gmbh: 1 patents #1 of 20Top 5%
AH Axcella Health: 1 patents #1 of 18Top 6%
IA Indigo Ag: 1 patents #9 of 52Top 20%
KB Kaleido Biosciences: 1 patents #1 of 5Top 20%
📍 Boston, MA: #19 of 1,211 inventorsTop 2%
🗺 Massachusetts: #190 of 13,863 inventorsTop 2%
Overall (2022): #13,216 of 548,613Top 3%
8
Patents 2022

Issued Patents 2022

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11464812 Synergistic bacterial compositions and methods of production and use thereof Matthew R. Henn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook +2 more 2022-10-11
11458173 Synergistic bacterial compositions and methods of production and use thereof Matthew R. Henn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook +2 more 2022-10-04
11458174 Synergistic bacterial compositions and methods of production and use thereof Matthew R. Henn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook +2 more 2022-10-04
11389490 Synergistic bacterial compositions and methods of production and use thereof Matthew R. Henn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook +2 more 2022-07-19
11357824 Nutritive polypeptides and formulations thereof, and methods of production and use thereof Michael Hamill, Brett Adam Boghigian, Caitlyn Harvey, David Arthur Berry, David M. Young +10 more 2022-06-14
11266699 Synergistic bacterial compositions and methods of production and use thereof Matthew R. Henn, Kevin Daniel Litcofsky, Anthony Mario D'Onofrio, Toshiro Kendrick Ohsumi, Mary-Jane Lombardo McKenzie +4 more 2022-03-08
11254908 Plants containing beneficial endophytes Birgit Mitter, Muhammad Naveed, Teresa Berninger, Stephane Compant, Angela Sessitsch +10 more 2022-02-22
11229660 Glycan therapeutics and method of treating conditions associated with TMAO Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia 2022-01-25